JP2006522102A5 - - Google Patents

Download PDF

Info

Publication number
JP2006522102A5
JP2006522102A5 JP2006507106A JP2006507106A JP2006522102A5 JP 2006522102 A5 JP2006522102 A5 JP 2006522102A5 JP 2006507106 A JP2006507106 A JP 2006507106A JP 2006507106 A JP2006507106 A JP 2006507106A JP 2006522102 A5 JP2006522102 A5 JP 2006522102A5
Authority
JP
Japan
Prior art keywords
agent according
molecule
trifunctional
trifunctional agent
pdt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006507106A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006522102A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/007525 external-priority patent/WO2004080483A1/en
Publication of JP2006522102A publication Critical patent/JP2006522102A/ja
Publication of JP2006522102A5 publication Critical patent/JP2006522102A5/ja
Pending legal-status Critical Current

Links

JP2006507106A 2003-03-10 2004-03-10 光診断法および光線力学的療法の両方のためのターゲット剤 Pending JP2006522102A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45361803P 2003-03-10 2003-03-10
PCT/US2004/007525 WO2004080483A1 (en) 2003-03-10 2004-03-10 Targeted agents for both photodiagnosis and photodynamic therapy

Publications (2)

Publication Number Publication Date
JP2006522102A JP2006522102A (ja) 2006-09-28
JP2006522102A5 true JP2006522102A5 (enExample) 2007-04-26

Family

ID=32990795

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006507106A Pending JP2006522102A (ja) 2003-03-10 2004-03-10 光診断法および光線力学的療法の両方のためのターゲット剤

Country Status (6)

Country Link
US (1) US20040247527A1 (enExample)
EP (1) EP1613351A1 (enExample)
JP (1) JP2006522102A (enExample)
AU (1) AU2004220530A1 (enExample)
CA (1) CA2523605A1 (enExample)
WO (1) WO2004080483A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7354433B2 (en) * 2003-02-28 2008-04-08 Advanced Light Technologies, Llc Disinfection, destruction of neoplastic growth, and sterilization by differential absorption of electromagnetic energy
US20110040295A1 (en) * 2003-02-28 2011-02-17 Photometics, Inc. Cancer treatment using selective photo-apoptosis
BRPI0519754A2 (pt) 2005-01-13 2009-03-10 Cinv Ag materiais compàsitos contendo nanopartÍculas de carbono
US20080268013A1 (en) * 2005-02-10 2008-10-30 Emory University Polyethylene Oxide Polymers Including Anti-Inflammatory Glycodendrons
US20080070802A1 (en) * 2006-08-23 2008-03-20 Moerschell Richard P Directed heterobifunctional linkers
US20090035576A1 (en) * 2006-09-08 2009-02-05 Prasad Paras N Nanoparticles for two-photon activated photodynamic therapy and imaging
US20080233051A1 (en) * 2006-09-08 2008-09-25 Prasad Paras N Nanoparticles for two-photon activated photodynamic therapy and imaging
JP2010519320A (ja) * 2007-02-28 2010-06-03 サノフィ−アベンティス イメージングプローブ
US20090069673A1 (en) * 2007-03-16 2009-03-12 The Charles Stark Draper Laboratory, Inc. Spinal needle optical sensor
SG172126A1 (en) * 2008-12-16 2011-07-28 Quadra Logic Tech Inc Combination of photodynamic therapy and anti-vegf agents in the treatment of unwanted choroidal neovasculature
WO2011037622A1 (en) * 2009-09-22 2011-03-31 Photometics Cancer treatment using selective photo-apoptosis
US8492339B2 (en) * 2009-10-26 2013-07-23 Empire Technology Development Llc Angiogenesis promoted by caged growth factors
WO2012176023A1 (en) 2011-06-23 2012-12-27 Indian Institute Of Technology Kanpur Hydrogel scaffolds for tissue engineering
AU2015284236B2 (en) 2014-06-30 2018-03-08 Tva (Abc), Llc Targeted conjugates and particles and formulations thereof
WO2016054079A1 (en) 2014-09-29 2016-04-07 Zyomed Corp. Systems and methods for blood glucose and other analyte detection and measurement using collision computing
EP3368546A4 (en) * 2015-10-28 2019-06-26 Tarveda Therapeutics, Inc. AGAINST SSTR CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6493570B1 (en) * 1998-11-02 2002-12-10 Photogen, Inc. Method for improved imaging and photodynamic therapy
US5832931A (en) * 1996-10-30 1998-11-10 Photogen, Inc. Method for improved selectivity in photo-activation and detection of molecular diagnostic agents
US6217848B1 (en) * 1999-05-20 2001-04-17 Mallinckrodt Inc. Cyanine and indocyanine dye bioconjugates for biomedical applications
US6395257B1 (en) * 2000-01-18 2002-05-28 Mallinckrodt Inc. Dendrimer precursor dyes for imaging
US20030017164A1 (en) * 2001-07-03 2003-01-23 Mallinckrodt Inc. Dye-azide compounds for dual phototherapy
US6939532B2 (en) * 2000-01-18 2005-09-06 Mallinckrodt, Inc. Versatile hydrophilic dyes
US7351807B2 (en) * 2000-01-18 2008-04-01 Mallinckrodt Inc. Cyanine-sulfenates for dual phototherapy
US20030031627A1 (en) * 2001-07-31 2003-02-13 Mallinckrodt Inc. Internal image antibodies for optical imaging and therapy
AU2002332608B2 (en) * 2001-08-22 2008-05-15 Montana State University-Bozeman Porphyrins with enhanced multi-photon absorption cross-sections for photodynamic therapy
US20030105300A1 (en) * 2001-10-17 2003-06-05 Mallinckrodt Inc. Tumor targeted photodiagnostic-phototherapeutic agents
US6761878B2 (en) * 2001-10-17 2004-07-13 Mallinckrodt, Inc. Pathological tissue detection and treatment employing targeted benzoindole optical agents
US20030105299A1 (en) * 2001-10-17 2003-06-05 Mallinckrodt Inc. Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications
US20030152577A1 (en) * 2002-02-07 2003-08-14 Mallinckrodt Inc. Dye-bioconjugates for simultaneous optical diagnostic and therapeutic applications

Similar Documents

Publication Publication Date Title
JP2006522102A5 (enExample)
Peng et al. Epitope molecularly imprinted polymer nanoparticles for chemo-/photodynamic synergistic cancer therapy guided by targeted fluorescence imaging
Wang et al. Photodynamic therapy: targeting cancer biomarkers for the treatment of cancers
Dolmans et al. Photodynamic therapy for cancer
Berg et al. Porphyrin‐related photosensitizers for cancer imaging and therapeutic applications
Dolmans et al. Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy
Zhang et al. A promising anticancer drug: A photosensitizer based on the porphyrin skeleton
Otvagin et al. Water-soluble chlorin/arylaminoquinazoline conjugate for photodynamic and targeted therapy
Brown et al. The present and future role of photodynamic therapy in cancer treatment
Sadanala et al. Sono-photodynamic combination therapy: a review on sensitizers
Hasan et al. Photodynamic therapy of cancer
CN102573613B (zh) 用于增强肿瘤显像的paa纳米粒子
Bhatti et al. Targeted photodynamic therapy with multiply‐loaded recombinant antibody fragments
ES2265047T3 (es) Clorinas sulfonadas como fotosensibilizadores.
JP4148328B2 (ja) 細胞サイトゾルへの化合物の移入
JP2021120406A5 (ja) 癌を治療するための組み合わせ物
Huang et al. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy
JP2005506344A5 (enExample)
JP2005506343A5 (enExample)
Cho et al. Injectable single-component peptide depot: autonomously rechargeable tumor photosensitization for repeated photodynamic therapy
Fang et al. Photodynamic therapy and imaging based on tumor-targeted nanoprobe, polymer-conjugated zinc protoporphyrin
JP2006517970A5 (enExample)
Mussini et al. Targeted photoimmunotherapy for cancer
Wong et al. Phthalaldehyde-amine capture reactions for bioconjugation and immobilization of phthalocyanines
Li et al. Phototheranostic Nanoagents for Imaging‐Guided Treatment of Oral Cancer